Vincerx Pharma (VINC) News Today $1.50 -0.06 (-3.85%) Closing price 04:00 PM EasternExtended Trading$1.48 -0.01 (-1.00%) As of 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period VINC stock touches 52-week low at $1.62 amid market challengesJanuary 30 at 3:45 AM | msn.comVincerx Pharma and Oqory reveal merger and cancer drug dataJanuary 30 at 3:45 AM | msn.comVincerx Pharma, Inc. (NASDAQ:VINC) Short Interest UpdateVincerx Pharma, Inc. (NASDAQ:VINC - Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 4,710,000 shares, an increase of 1,022.5% from the December 31st total of 419,600 shares. Based on an average daily trading volume, of 6,840,000 shares, the short-interest ratio is currently 0.7 days.January 29 at 6:31 PM | marketbeat.comVincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258January 29 at 9:35 AM | markets.businessinsider.comVincerx Pharma Inc trading halted, news pendingJanuary 28 at 1:29 AM | markets.businessinsider.comVincerx Pharma files $100M mixed securities shelfJanuary 24, 2025 | markets.businessinsider.comPalo Alto's Vincerx Pharma plans reverse stock split amid merger plansJanuary 24, 2025 | bizjournals.comVincerx Pharma board aproves 1-for-20 reverse stock splitJanuary 24, 2025 | markets.businessinsider.comVincerx Pharma, Inc. Announces Reverse Stock SplitJanuary 23, 2025 | investing.comVincerx Pharma, Inc. Announces Reverse Stock SplitJanuary 23, 2025 | globenewswire.comVincerx Pharma enters at-the-market equity offering dealJanuary 21, 2025 | msn.comVincerx Pharma Inc Ordinary SharesJanuary 14, 2025 | morningstar.comInvestor law firms question biotech merger's 'fairness'January 7, 2025 | bizjournals.comVINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINCJanuary 6, 2025 | businesswire.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Vincerx Pharma, Inc. MergerJanuary 3, 2025 | markets.businessinsider.comVINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to ShareholdersDecember 30, 2024 | businesswire.comShareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public ShareholdersDecember 30, 2024 | businesswire.comVincerx Pharma Stock Rises On Proposed Merger With Oqory: Retail Remains BullishDecember 30, 2024 | msn.comVincerx Pharma, Inc.: Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.December 28, 2024 | finanznachrichten.deVincerx Pharma To Merge With Oqory; Cuts JobsDecember 28, 2024 | markets.businessinsider.comVincerx Pharma enters binding term sheet for merger with OqoryDecember 27, 2024 | markets.businessinsider.comVincerx Pharma To Be Acquired by Private Biotech, Cut HeadcountDecember 27, 2024 | marketwatch.comVincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.December 27, 2024 | globenewswire.comVincerx Pharma Stock Gets Retail Followers Buzzing With Big Layoff Plans To Sustain Cancer Drug TrialsDecember 5, 2024 | msn.comVincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943December 4, 2024 | globenewswire.comVincerx Pharma Inc: Strategic Advancements and Promising Pipeline Highlight Buy RatingNovember 14, 2024 | markets.businessinsider.comVincerx Pharma, Inc.: Vincerx Pharma Reports Third Quarter 2024 Financial ResultsNovember 13, 2024 | finanznachrichten.deVincerx Pharma Reports Q3 2024 Financial ResultsNovember 13, 2024 | markets.businessinsider.comVincerx Pharma: A Strong Buy on Promising VIP943 Clinical Results and Strategic FocusOctober 9, 2024 | markets.businessinsider.comPenny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer CandidatesOctober 8, 2024 | benzinga.comVincerx Reports Positive Initial Clinical Data From VIP943 Phase 1 Dose-Escalation StudyOctober 8, 2024 | markets.businessinsider.comVincerx Pharma (NASDAQ:VINC) Stock, Insider Trading ActivityOctober 7, 2024 | benzinga.comVincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate UpdatesOctober 7, 2024 | globenewswire.comVincerx Pharma (NASDAQ:VINC) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comCompanies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite RiskyAugust 21, 2024 | finance.yahoo.comBuy Rating Affirmed for Vincerx Pharma Amid Positive Clinical Progress and Stable Financial OutlookAugust 14, 2024 | markets.businessinsider.comVINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024August 9, 2024 | investorplace.comVincerx Pharma Reports Second Quarter 2024 Financial ResultsAugust 8, 2024 | globenewswire.comVincerx Pharma GAAP EPS of -$0.58May 15, 2024 | msn.comVincerx Pharma, Inc.: Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | finanznachrichten.deVINC Stock Earnings: Vincerx Pharma Misses EPS for Q1 2024May 14, 2024 | investorplace.comVincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | globenewswire.comWhy Vincerx Pharma (VINC) Stock Is FallingApril 26, 2024 | msn.comVincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsApril 26, 2024 | globenewswire.comVincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and WarrantsApril 25, 2024 | globenewswire.comVincerx Pharma, Inc. Common Stock (VINC)April 23, 2024 | nasdaq.comAgendia’s BluePrint Included in German Oncology Group GuidelinesApril 12, 2024 | finance.yahoo.comThe Rise of Zyn: The Oral Nicotine Product Going ViralApril 10, 2024 | finance.yahoo.comVincerx Pharma Inc (VINC) Gets a Buy from Leerink PartnersApril 10, 2024 | markets.businessinsider.comTrading was temporarily halted for "VINC" at 09:04 AM with a stated reason of "LULD pause."April 9, 2024 | marketbeat.com Get Vincerx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VINC and its competitors with MarketBeat's FREE daily newsletter. Email Address VINC Media Mentions By Week VINC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VINC News Sentiment▼0.300.75▲Average Medical News Sentiment VINC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VINC Articles This Week▼141▲VINC Articles Average Week Get Vincerx Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VINC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TXMD News Today SNSE News Today HCWB News Today CHRO News Today TLPH News Today FLGC News Today BMRA News Today BCLI News Today EGRX News Today KPRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VINC) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
